Group 1 - The company Yongtai Biological-B (06978) issued convertible bonds on February 20, 2023, which will mature on February 20, 2026 [1] - A framework agreement was established with investor Jiaze Global Capital Limited, the existing holder of the 2023 convertible bonds, for the subscription of new convertible bonds worth 270 million HKD and notes worth 30 million HKD [1] - The proceeds from the subscription will be used exclusively for the full and final repayment of the principal amount of the 2023 convertible bonds [1] Group 2 - The initial conversion price of the new convertible bonds is set at 2.92 HKD per share, which represents a premium of approximately 5.8% over the last trading price of 2.76 HKD per share on the Hong Kong Stock Exchange [1]
永泰生物-B拟向嘉泽全球资本发行2.7亿元的新可换股债券及3000万元的票据以清偿2023年可换股债券的本金额